Influence of acute renal failure on coronary vasoregulation in dogs

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1316-1324

  Kingma, John G ^a   Vincent, Chantal ^a   Rouleau, Jacques R ^a   Kingma, Iris ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSPHERE; NITRIC OXIDE; PROSTAGLANDIN;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTERY TONE; ARTICLE; BLOOD VESSEL FUNCTION; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; DEATH; EVALUATION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART VENTRICLE; HYPEREMIA; INTRACORONARY INFUSION; NONHUMAN; OXYGEN SUPPLY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; REST; RISK FACTOR;

EID: 33646368913     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101084     Document Type: Article

References (42)

1. Ympa YP, Sakr Y, Reinhart K, Vincent JL: Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 118: 827-832, 2005
2. Freeman RV, Mehta RH, Al BW, Cooper JV, Kline-Rogers E, Eagle KA: Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. J Am Coll Cardiol 41: 718-724, 2003
3. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA: Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351: 1285-1295, 2004
4. USRDS 2004 annual data report. Am J Kidney Dis 45:8-280, 2005
5. Koreny M, Karth GD, Geppert A, Neunteufl T, Priglinger U, Heinz G, Siostrzonek P: Prognosis of patients who develop acute renal failure during the first 24 hours of cardiogenic shock after myocardial infarction. Am J Med 112:115-119, 2002
6. Zanchetti A, Stella A: Cardiovascular disease and the kidney: An epidemiologic overview. J Cardiovasc Pharmacol 33[Suppl 1]: S1-S6, 1999
7. London GM, Marchais SJ, Guerin AP, Metivier F, Adda H: Arterial structure and function in end-stage renal disease. Nephrol Dial Transplant 17: 1713-1724, 2002
8. Munagala VK, Hart CY, Burnett JC Jr, Meyer DM, Redfield MM: Ventricular structure and function in aged dogs with renal hypertension: A model of experimental diastolic heart failure. Circulation 111: 1128-1135, 2005
9. Rouleau JR, Boerboom LE, Surjadhana A, Hoffman JIE: The role of autoregulation and tissue diastolic pressures in the transmural distribution of left ventricular blood flow in anesthetized dogs. Circ Res 45: 804-815, 1979
10. Mosher P, Ross J Jr, McFate PA, Shaw RF: Control of coronary blood flow by an autoregulatory mechanism. Circ Res 14: 250-259, 1964
11. Canty JM Jr. Coronary pressure-function and steady-state pressure-flow relations during autoregulation in the unanesthetized dog. Circ Res 63: 821-836, 1988
12. Sellke FW, Myers PR, Bates JN, Harrison DG: Influence of vessel size on the sensitivity of porcine coronary microvessels to nitroglycerin. Am J Physiol 258: H515-H520, 1990
13. Rouleau JR, Simard D, Kingma JG Jr: Myocardial blood flow regulation relative to left ventricle pressure and volume in anesthetized dogs. Can J Physiol Pharmacol 77: 902-908, 1999
14. Hoffman JIE, Spaan JAE: Pressure-flow relations in coronary circulation. Physiol Rev 70: 331-390, 1990
15. Messina LM, Hanley FL, Uhlig PN, Baer RW, Grattan MT, Hoffman JIE: Effects of pressure gradients between branches of the left coronary artery on the pressure axis intercept and the shape of steady state circumflex pressure-flow relations in dogs. Circ Res 56: 11-19, 1985
16. Rouleau JR, Simard D, Rodrigue N, Blouin A, Kingma JG Jr: Myocardial blood flow after chronic cardiac decentralization in anesthetized dogs: Effects of ACE-inhibition. Auton Neurosci 97: 12-18, 2002
17. Ferguson DW: Sympathetic mechanisms in heart failure. Pathophysiological and pharmacological implications. Circulation 87: VII-68-VII-75, 1993
18. Benetos A, Albaladejo P, Levy BI, Safar ME: Acute and long-term effects of angiotensin-converting enzyme inhibition on larger arteries and cardiac hypertrophy: Mechanical and structural parameters. J Hypertens 12: S21-S29, 1994
19. Zanzinger J, Zheng X, Bassenge E: Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism. Cardiovasc Res 28: 209-214, 1994
20. Sato N, Shen Y-T, Kiuchi K, Shannon RP, Vatner SF: Splenic contraction-induced increases in arterial O2 reduce requirement for CBF in conscious dogs. Am J Physiol Heart Circ Physiol 269: H491-H503, 1995
21. Kingma JG Jr, Plante S, Bogaty P: Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion. J Am Coll Cardiol 36: 2317-2324, 2000
22. Rouleau JR, Simard D, Blouin A, Kingma JG Jr: Angiotensin inhibition and coronary autoregulation in a canine model of LV hypertrophy. Basic Res Cardiol 97: 384-391, 2002
23. Rouleau JR, Simard D, Kingma JG: Effect of angiotensin inhibition on the coronary artery lower pressure limit in anesthetized dogs. Can J Physiol Pharmacol 78: 892-896, 2000
24. Parent R, Hamdad N, Ming Z, Lavallee M: Contrasting effects of blockade of nitric oxide formation on resistance and conductance coronary vessels in conscious dogs. Cardiovasc Res 31: 555-567, 1996
25. Sudhir K, Chou TM, Hutchison SJ, Chatterjee K: Coronary vasodilation induced by angiotensin-converting enzyme inhibition in vivo: Differential contribution of nitric oxide and bradykinin in conductance and resistance arteries. Circulation 93: 1734-1739, 1996
26. Gallagher KP, Matsuzaki M, Koziol JA, Kemper WS, Ross J Jr: Regional myocardial perfusion and wall thickening during ischemia in conscious dogs. Am J Physiol Heart Circ Physiol 247: H727-H738, 1984
27. Repeated measures ANOVA using the SAS GLM Procedure. In: SAS User's Guide: Statistics, 5th ed., Cary, NC, SAS Institute, 1985, pp 475-485
28. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362: 801-809, 1993
29. Levine GN, Keaney JF Jr, Vita JA: Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 332: 512-521, 1995
30. Ragosta M, Samady H, Isaacs RB, Gimple LW, Sarembock IJ, Powers ER: Coronary flow reserve abnormalities in patients with diabetes mellitus who have end-stage renal disease and normal epicardial coronary arteries. Am Heart J 147: 1017-1023, 2004
31. Traverse JH, Chen Y, Crampton M, Voss S, Bache RJ: Increased extravascular forces limit endothelium-dependent and -independent coronary vasodilation in congestive heart failure. Cardiovasc Res 52: 454-461, 2001
32. Tune JD, Gorman MW, Feigl EO: Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97: 404-415, 2004
33. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ: Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203, 1995
34. Ruschitzka F, Shaw S, Gygi D, Noll G, Barton M, Luscher TF: Endothelial dysfunction in acute renal failure: Role of circulating and tissue endothelin-1. J Am Soc Nephrol 10: 953-962, 1999
35. Jeremy JY, Rowe D, Emsley AM, Newby AC: Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc Res 43: 580-594, 1999
36. Mackie FE, Meyer TW, Campbell DJ: Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency. Kidney Int 61: 555-563, 2002
37. McGiff JC, Terragno NA, Malik KU, Lonigro AJ: Release of a prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31: 36-43, 1972
38. Lariviere R, Lebel M: Endothelin-1 in chronic renal failure and hypertension. Can J Physiol Pharmacol 81: 607-621, 2003
39. Wang W, Jittikanont S, Falk SA, Li P, Feng L, Gengaro PE, Poole BD, Bowler RP, Day BJ, Crapo JD, Schrier RW: Interaction among nitric oxide, reactive oxygen species, and antioxidants during endotoxemia-related acute renal failure. Am J Physiol Renal Physiol 284: F532-F537, 2003
40. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
41. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 16: 31-41, 1976
42. Schetz MR: Coagulation disorders in acute renal failure. Kidney Int Suppl 66: S96-S101, 1998